Rhythm Pharmaceuticals Inc banner

Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 90.51 USD 3.58% Market Closed
Market Cap: $6.2B

Wall Street
Price Targets

RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc

Wall Street analysts forecast RYTM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RYTM is 142.61 USD with a low forecast of 111.1 USD and a high forecast of 175.35 USD.

Lowest
Price Target
111.1 USD
23% Upside
Average
Price Target
142.61 USD
58% Upside
Highest
Price Target
175.35 USD
94% Upside
Rhythm Pharmaceuticals Inc Competitors:
Price Targets
RYI
Ryerson Holding Corp
51% Upside
ZNTL
Zentalis Pharmaceuticals Inc
81% Upside
LAND
Gladstone Land Corp
-10% Downside
PRQR
ProQR Therapeutics NV
422% Upside
SDGR
Schrodinger Inc
104% Upside

Revenue
Forecast

N/A
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

The compound annual growth rate of Rhythm Pharmaceuticals Inc's revenue for the next 3 years is 71%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RYTM's stock price target?
Price Target
142.61 USD

According to Wall Street analysts, the average 1-year price target for RYTM is 142.61 USD with a low forecast of 111.1 USD and a high forecast of 175.35 USD.

What is Rhythm Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
71%

The compound annual growth rate of Rhythm Pharmaceuticals Inc's revenue for the next 3 years is 71%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett